American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 29, Issue 2 , Pages 94-100 , March 2008

Parotid tumors: a 10-year experience

  • Ching-Chia Lin, MD

      Affiliations

    • Department of Otolaryngology, China Medical University Hospital, Taichung, Taiwan
    • ,
  • Ming-Hsui Tsai, MD

      Affiliations

    • Department of Otolaryngology, China Medical University Hospital, Taichung, Taiwan
    • Corresponding Author InformationCorresponding author. Department of Otolaryngology, China Medical University Hospital, No. 2, Yuh-Der Road, Taichung 404, Taiwan, R.O.C. Tel.: +886 4 22052121 4436; fax: +886 4 22052121 4438.
    • ,
  • Chiu-Chen Huang, PhD

      Affiliations

    • Department of Medical Laboratory Science and Biotechnology, Yuanpei University, Hsinchu, Taiwan
    • ,
  • Chun-Hung Hua, MD

      Affiliations

    • Department of Otolaryngology, China Medical University Hospital, Taichung, Taiwan
    • ,
  • Hsian-Chang Tseng, MD

      Affiliations

    • Department of Otolaryngology, China Medical University Hospital, Taichung, Taiwan
    • ,
  • Shih-Tzu Huang, PhD

      Affiliations

    • School of Nursing, Fooyin University, Kaohsiung, Taiwan

Received 30 January 2007

References 

  1. Przewozny T, Stankiewicz C. Neoplasms of the parotid gland in northern Poland, 1991–2000: an epidemiologic study. Eur Arch Otorhinolaryngol. 2004;261:369–375
  2. Bradley PJ. Pleomorphic salivary adenoma of the parotid gland: which operation to perform?. Curr Opin Otolaryngol Head Neck Surg. 2004;12:69–70
  3. Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2807 patients. Head Neck Surg. 1986;8:177–184
  4. Eveson JW, Cawson RA. Salivary gland tumors. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol. 1985;146:51–58
  5. Eneroth CM. Salivary gland tumors in the parotid gland, submandibular gland, and the palate region. Cancer. 1971;27:1415–1418
  6. Lim LHY, Chao SS, Goh CHK, et al. Parotid gland surgery: 4-year review of 118 cases in an Asian population. Head Neck. 2003;25:543–548
  7. Chung YFA, Khoo MLC, Heng MKD, et al. Epidemiology of Warthin's tumour of the parotid gland in an Asian population. Br J Surg. 1999;86:661–664
  8. Harish K. Management of primary malignant epithelial parotid tumors. Surg Oncol. 2004;13:7–16
  9. Spiro RH, Huvos AG, Strong EW. Cancer of the parotid gland. A clincopathologic study of 288 primary cases. Am J Surg. 1975;130:452–459
  10. Urquhart A, Hutchins LG, Berg RL. Preoperative computed tomography scans for parotid tumor evaluation. Laryngoscope. 2001;111:1984–1988
  11. Bova R, Saylor A, Coman WB. Parotidectomy: review of treatment and outcomes. ANZ J Surg. 2004;74:563–568
  12. Awan MS, Ahmad Z. Diagnostic value of fine needle aspiration cytology in parotid tumors. JPMA. 2004;54:617–649
  13. Aversa S, Ondolo C, Bollito E, et al. Preoperative cytology in the management of parotid neoplasms. Am J Otolaryngol. 2006;27:96–100
  14. Seethala RR, LiVolsi VA, Baloch ZW. Relative accuracy of fine-needle aspiration and frozen section in the diagnosis of lesions of the parotid gland. Head Neck. 2005;27:217–223
  15. Bahar G, Dudkiewicz M, Feinmesser R, et al. Acute parotiditis as a complication of fine-needle aspiration in Warthin's tumor. A unique finding of a 3-year experience with parotid tumor aspiration. Otolaryngol Head Neck Surg. 2006;134:646–649
  16. Zbaren P, Tschumi I, Nuyens M, et al. Recurrent pleomorphic adenoma of the parotid gland. Am J Surg. 2005;189:203–207
  17. Leonetti JP, Marzo SJ, Petruzzelli GJ, et al. Recurrent pleomorphic adenoma of the parotid gland. Otolaryngol Head Neck Surg. 2005;133:319–322
  18. Nouraei SAR, Hope KL, Kelly CG, et al. Carcinoma ex benign pleomorphic adenoma of the parotid gland. Plast Reconstr Surg. 2005;116:1206–1213
  19. Kennedy TL. Warthin's tumor: a review indicating no male predominance. Laryngoscope. 1983;93:889–891
  20. Eveson JW, Cawson RA. Warthin's tumor (cystadenolymphoma) of salivary glands. A clinicopathologic investigation of 278 cases. Oral Surg Oral Med Oral Pathol. 1986;61:256–262
  21. Yoo GH, Eisele DW, Askin FB, et al. Warthin's tumor: a 40-year experience at The Johns Hopkins Hospital. Laryngoscope. 1994;104:799–803
  22. Seifert G, Donath K. Multiple tumors of the salivary glands—terminology and nomenclature. Oral Oncol Eur J Cancer. 1996;32:3–7
  23. Batsakis JG, el-Naggar AK. Warthin's tumor. Ann Otol Rhinol Laryngol. 1990;99:588–591
  24. Guntinas-Lichius O, Klussmann JP, Wittekindt C, et al. Parotidetomy for benign parotid disease at a university teaching hospital: outcome of 963 operations. Laryngoscope. 2006;116:534–540
  25. Salamah SMA, Khalid K, Khan IAR, et al. Outcome of surgery for parotid tumors: 5-year experience of a general surgical unit in a teaching hospital. ANZ J Surg. 2005;75:948–952
  26. Astro FC, Ackerman EB, Hanft KL, et al. Surgical treatment of parotid tumors in the general community hospital. South Med J. 2002;95:1404–1407
  27. Dulguerov P, Marchal F, Lehmann W. Postparotidectomy facial nerve paralysis: possible etiologic factors and results with routine facial nerve monitoring. Laryngoscope. 1999;109:754–762
  28. Christophe G, Sophie P, Bertrand S, et al. Facial nerve dysfunction after parotidectomy: the role of local factors. Laryngoscope. 2005;115:287–291
  29. Umapathy N, Holmes R, Basavaraj S, et al. Performance of parotidectomy in nonspecialist centers. Arch Otolaryngol Head Neck Surg. 2003;129:925–928
  30. Marshall AH, Quraishi SM, Bradley PJ. Patients' perspectives on the short- and long-term outcomes following surgery for benign parotid neoplasms. J Laryngol Otol. 2003;117:624–629
  31. Broderick JP, Auger RG, DeSanto LW. Facial paralysis and occult parotid cancer. A characteristic syndrome. Arch Otolaryngol Head Neck Surg. 1988;114:195–197
  32. DeLozier HL, Spinella MJ, Johnson GD. Facial nerve paralysis with benign parotid masses. Ann Otol Rhinol Laryngol. 1989;98:644–647
  33. Lima RA, Tavares MR, Dias FL, et al. Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol head Neck Surg. 2005;133:702–708
  34. Armstrong JG, Harrison LB, Thaler HT, et al. The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer. 1992;69:615–619
  35. Bhattacharyya N, Fried MP. Nodal metastasis in major salivary gland cancer: predictive factors and effects on survival. Arch Otolaryngol Head Neck Surg. 2002;128:904–908
  36. Pohar S, Gay H, Rosenbaum P, et al. Malignant parotid tumors: presentation, clinical/pathologic prognostic factors, and treatment outcomes. Int J Radiat Oncol Biol Phys. 2005;61:112–118

PII: S0196-0709(07)00039-7

doi: 10.1016/j.amjoto.2007.03.002

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 29, Issue 2 , Pages 94-100 , March 2008

Article Tools

* Image Usage & Resolution